Key Takeaways
- Methamphetamine hydrochloride, commonly known as crystal meth, has a molecular formula of C10H15N·HCl and a molecular weight of 185.69 g/mol
- Crystal meth is typically produced via reduction of ephedrine or pseudoephedrine using red phosphorus and hydroiodic acid, yielding purity levels up to 99% in clandestine labs
- The melting point of pure methamphetamine base is 170-175°C, while the hydrochloride salt melts at 172°C
- In 2022, 27 million people aged 12+ used meth in the past year globally, per UNODC estimates
- US past-year meth use among adults 26+ rose 50% from 2015-2019 to 1.7%
- Among US treatment admissions, meth accounted for 23% in 2021, up from 10% in 2010
- Chronic meth use causes 20-30% dopamine transporter loss after 1 year
- Meth increases heart rate by 20-50 bpm and blood pressure by 20-40 mmHg acutely
- Long-term meth use leads to cardiomyopathy in 25-44% of users
- Meth psychosis mimics schizophrenia with 40% dopamine receptor upregulation
- 40-50% of chronic meth users develop psychosis lasting >1 month
- Meth-induced aggression increases violence risk 3x in users
- US meth trafficking indictments 1,200 annually
- Meth possession carries 5-40 year sentences federally if >5g pure
- US meth wholesale price $3,000-$6,000 per lb in 2022
The production of crystal meth involves dangerous chemical processes, and its use continues to inflict profound personal harm and widespread societal costs into 2026.
Chemical Properties and Production
Chemical Properties and Production Interpretation
Epidemiology and Usage Statistics
Epidemiology and Usage Statistics Interpretation
Legal, Economic, and Societal Impacts
Legal, Economic, and Societal Impacts Interpretation
Physiological and Health Effects
Physiological and Health Effects Interpretation
Psychological and Behavioral Effects
Psychological and Behavioral Effects Interpretation
Sources & References
- Reference 1PUBCHEMpubchem.ncbi.nlm.nih.govVisit source
- Reference 2DEAdea.govVisit source
- Reference 3NCBIncbi.nlm.nih.govVisit source
- Reference 4JUSTICEjustice.govVisit source
- Reference 5DRUGBANKdrugbank.caVisit source
- Reference 6USDOJusdoj.govVisit source
- Reference 7SIGMAALDRICHsigmaaldrich.comVisit source
- Reference 8SWGDRUGswgdrug.orgVisit source
- Reference 9EMCDDAemcdda.europa.euVisit source
- Reference 10PUBSpubs.acs.orgVisit source
- Reference 11WEBBOOKwebbook.nist.govVisit source
- Reference 12UNODCunodc.orgVisit source
- Reference 13FORENSICMAGforensicmag.comVisit source
- Reference 14PHARMACOLOGY2000pharmacology2000.comVisit source
- Reference 15ATFatf.govVisit source
- Reference 16FDAfda.govVisit source
- Reference 17USPusp.orgVisit source
- Reference 18EPAepa.govVisit source
- Reference 19NIDAnida.nih.govVisit source
- Reference 20SAMHSAsamhsa.govVisit source
- Reference 21MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 22CDCcdc.govVisit source
- Reference 23VAva.govVisit source
- Reference 24AIHWaihw.gov.auVisit source
- Reference 25WWWDASISwwwdasis.samhsa.govVisit source
- Reference 26HUDUSERhuduser.govVisit source
- Reference 27BOPbop.govVisit source
- Reference 28RURALHEALTHruralhealth.und.eduVisit source
- Reference 29AHAJOURNALSahajournals.orgVisit source
- Reference 30JNEUROSCIjneurosci.orgVisit source
- Reference 31KIDNEYkidney.orgVisit source
- Reference 32PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 33RANDrand.orgVisit source
- Reference 34STATEstate.govVisit source
- Reference 35ACFacf.hhs.govVisit source
- Reference 36NCSLncsl.orgVisit source
- Reference 37BJSbjs.govVisit source
- Reference 38PRISONPOLICYprisonpolicy.orgVisit source
- Reference 39USFAusfa.fema.govVisit source
- Reference 40OJPojp.govVisit source
- Reference 41USCODEuscode.house.govVisit source
- Reference 42CBPcbp.govVisit source
- Reference 43NCJRSncjrs.govVisit source






